George Magrath - Dec 23, 2024 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role
Chief Executive Officer
Signature
/s/ Amy Rabourn, by Power of Attorney
Stock symbol
IRD
Transactions as of
Dec 23, 2024
Transactions value $
$0
Form type
4
Date filed
12/23/2024, 05:50 PM
Previous filing
Nov 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRD Common Stock Award $0 +6.2K +1.26% $0.00 499K Dec 23, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to the Reporting Person to correct an inadvertent over-withholding of shares on November 1, 2024, in connection with the vesting of restricted stock units on that date.